Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
1,721
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Jul 29, 2011

Dr. Jane Lebkowski, executive vice president and chief scientific officer at Geron Corporation, gave the keynote address for the 2011 CIRM Bridges Trainee Meeting. Last year, Geron began the first clinical trial in the world using human embryonic stem cells. CIRM recently approved a $25 million loan to Geron to assist in this trial. The embryonic stem cells used in the trial are being tested as a potential therapy for spinal cord injury. Lebkowski reviewed the work leading up to the trial and gave the latest update on its progress. Lebkowski was introduced by Art Torres, vice chair of the CIRM Governing Board, and Pat Olson, executive director of CIRM scientific activities.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (2)

Sign In or Sign Up now to post a comment!
  • nice info thanks fo info in video

  • Translation button would be good for this video... "So your saying there's a chance!?"

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more